Viking Therapeutics VKTX Total Equity
Total Equity at other companies
Other financials
Where this comes from
Reported directly by Viking Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:StockholdersEquity.
The official record: Viking Therapeutics’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Viking Therapeutics's total equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Viking Therapeutics's total equity?
- Viking Therapeutics (VKTX) reported total equity of $501.92M in Q1 2026.
- How has Viking Therapeutics's total equity changed year-over-year?
- Viking Therapeutics's total equity decreased by 40.7% year-over-year, from $846.92M to $501.92M.
- What is the long-term trend for Viking Therapeutics's total equity?
- Over 5 years (2020 to 2025), Viking Therapeutics's total equity has grown at a 21.2% compound annual growth rate (CAGR), from $244.34M to $639.06M.
- What does total equity mean?
- Net assets attributable to shareholders — total assets minus total liabilities. Represents the book value of shareholders' ownership claim.